Roman Rybin also spoke about the results of reorganization that took place at ARRIAH, and outlined the challenges faced by the great team of the institution.
On the development of new animal vaccines
Roman Nikolayevich, Russian manufacturers are currently facing the challenge of import substitution, which includes animal health products as well. How is ARRIAH involved in that?
Roman Rybin: The institution keeps working on the development of new animal vaccines. I would like to note, that locally and globally it has established itself as the leading Russian research and production center, that focuses on disease control and treatment both in farm and companion animals. It is also a reference center for Rosselkhoznadzor.
As for our export activities, we supply veterinary drugs to 25 countries all over the world.
I would like to note, that this year we have increased overseas supplies of immunobiologicals by 50% compared to the previous year. Besides that, our supplies to the local market have also increased significantly. This year, domestic sales of ARRIAH animal health products have increased by 85% compared to the previous year.
Significant increase in sales. What makes it possible?
Roman Rybin: I must say that this activity is to the large extent inspired by the sanctions imposed against Russia by unfriendly countries. They encourage us to ramp up production and sales of animal vaccines.
Our major task today is to provide substitutes for all farm animal vaccines that used to be imported to Russia from other countries. FGBI ARRIAH intends to cover all needs of Russian livestock farmers for veterinary drugs.
What is the present capacity of ARRIAH in terms of animal vaccine supplies to the local market?
Roman Rybin: We have been working on the substitution of imported vaccines since February, and we have set our priorities in that field. We are currently working in collaboration with the Russian State Center for Animal Feed and Drug Standardization and Quality of Rosselkhoznadzor (FGBI “VGNKI”).
I would like to say, that currently we are able to cover 85% of the needs of the Russian market for vaccines against viral diseases of farm and companion animals.
However, we keep perusing the goal of the import substitution, and in my opinion, we will be able to show great results by the end of the year, which will allow agricultural producers to choose FGBI ARRIAH’s products over other animal vaccines.
